| Pharmaceutical active ingredients: |
| Antihemophilic Factor Human |
| Available forms, composition and doses of Kryobulin VH: |
| Injectable; Injection; Antihemophilic Factor Human 1000 unitsInjectable; Injection; Antihemophilic Factor Human 500 units |
| Kryobulin VH medical category: |
| Human:Hemostatics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| B02BD02 - Coagulation Factor VIII |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| BaxterOsterreichisches Institut fur Haemoderivate |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Octaglob-D | Anti-D Immune Globulin; Glycine Stabilizer | Octapharma |
| Stomagel | Antifoam Emulsion; Bentonite; Calcium Carbonate; Magnesium Trisilicate | Darya-Varia Laboratoria |
| Rhinovac | Antigen Extracts | Darrow Laboratorios |
| Factorate | Antihemophilic Factor Human | Armour Pharmaceutical |
| Koate-HP | Antihemophilic Factor Human | Bayer Schering Pharma; Cutter Biological |
| Profilate Heat Treated-Wet Method | Antihemophilic Factor Human | Alpha Therapeutic Corporation |
| Feiba VH Immuno Anti Inhibitor | Antihemophilic Factor Human; Coagulation Factor II Human; Coagulation Factor IX Complex Human; Coagulation Factor VII Human; Coagulation Factor X Human | Osterreichisches Institut fur Haemoderivate |
| Wilate | Antihemophilic Factor Human; Plasma Proteins Human; Von Willebrand Factor Human | Octapharma |
| Iort 3 | Antihemophilic Factor Monoclonal Antibody purified pasteurized | USV, India |
| Helixate FS | Antihemophilic Factor recombinant | Bayer Schering Pharma; Sanofi-Aventis |